TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/04/2023
Voltar para busca
Dado oficial do USPTO
CDS CLINICAL DIAGNOSTIC SOLUTIONS, INC.
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
18/04/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1
Data de depósito
08/03/2011
Data de registro
07/08/2012
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/10/2021
Última transação
15/10/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
22/04/1999
Primeiro uso no comércio
13/07/1999
Código do desenho
3
Tipo de titular
03
Localização do titular
Plantation, FL
Examinador
YARD, JOHN S
Unidade examinadora
M60
Localização atual
GENERIC WEB UPDATE
Descrição da marca
The mark consists of the letter "C" and the letter "D" combined to form the letter "S" with three small triangles all superimposed on two large triangles, all to the left of the words "CLINICAL DIAGNOSTIC SOLUTIONS, INC."
Titulares e representantes
Titulares
Clinical Diagnostic Solutions, Inc.
Representantes
Ronald N. Rosenwasser FRIEDMAN ROSENWASSER & GOLDBAUM PA
Classificação técnica
Classes Nice
Classe 1
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemical reagentslytic reagentsquench reagentsenzyme reagentsrinsing reagents and cleaning reagents all for use with hematologyand/or chemical analytical automated and semi-automated study and analysis instrumentsmachines and systems used in diagnosticindustrialbiologicalcytology laboratories all for scientific use in the human clinical laboratory testing market; reagents kits comprising reagents and buffer and standard solutions used in analytical chemistry packaged in ready-to-use dispensing packages for scientific use in the human clinical laboratory testing market; fluorescent dyes for scientific usefor microscopic specimen slides and flow cytometry; Synthetic resin compounds in the form of microspheres used to incorporate other substancesmonodispersed test particles for use as standardscalibrators and carrier receptor sites employed with cytology and particle study and analysis instruments and systems used in the biologicalindustrialand/or academic fields for scientific use in the human clinical laboratory testing market; calibrating and quality control fluid for blood analyzerswhole blood hematology reference control solutions for calibration in electronic particle laboratory analysis for diagnosticscientific use in the human clinical testing laboratory testing market; Chemicalsbuffer and standard solutions used in analytical chemistry; Biochemical flow cytometry sheath fluids for scientific use; diagnostic laboratory reagents for hemoglobin testing for scientific use; reagents for use with automatic chemical analysis instruments in biologicalchemicalindustrialclinical laboratories for scientific use in the human clinical laboratory testing market
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/04/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
15/10/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
15/10/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
15/10/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/09/2021
PUM2
OFFICE ACTION ISSUED POU2
03/09/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
23/08/2021
PUM1
OFFICE ACTION ISSUED POU1
20/08/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/08/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
10/08/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/08/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
15/04/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
15/04/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/04/2018
E815
TEAS SECTION 8 & 15 RECEIVED
05/04/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/12/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/08/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/05/2012
PUBO
PUBLISHED FOR OPPOSITION
22/05/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/04/2012
ALIE
ASSIGNED TO LIE
17/04/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/03/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/03/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/03/2012
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
27/03/2012
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
25/01/2012
GNFR
FINAL REFUSAL E-MAILED
25/01/2012
CNFR
FINAL REFUSAL WRITTEN
25/01/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/06/2011
GNRT
NON-FINAL ACTION E-MAILED
15/06/2011
CNRT
NON-FINAL ACTION WRITTEN
15/06/2011
DOCK
ASSIGNED TO EXAMINER
08/06/2011
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
12/03/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/03/2011
NWAP
NEW APPLICATION ENTERED
11/03/2011
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CDS CLINICAL DIAGNOSTIC SOLUTIONS, INC. ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.